Back to Search
REBECCA SHOEMAKER, MD
MD
Pain Medicine (Physical Medicine & Rehabilitation) Physician
NPI: 1275978017IndividualAccepts Medicare
Specialties, Licenses & Credentials
Pain Medicine Physician
Pain Medicine — Pain Medicine
Code: 208VP0000X
00116028976(VA)
Pain Medicine (Physical Medicine & Rehabilitation) PhysicianPrimary
Physical Medicine & Rehabilitation — Pain Medicine
Code: 2081P2900X
0101263940(VA)
CMS Specialties
PrimaryPAIN MANAGEMENT
Education
VIRGINIA COMMONWEALTH UNIVERSITY, SCHOOL OF MEDICINE
Class of 2012
Research & Publications (20)
Synergistic antitumor activity of oncolytic reovirus and chemotherapeutic agents in non-small cell lung cancer cells.
PMID 19594950·Mol Cancer·2009
8-other
Identification and analyses of candidate genes for rpp4-mediated resistance to Asian soybean rust in soybean.
PMID 19251904·Plant Physiol·2009
8-other
LiCB(11)(CH(3))(12)-catalyzed radical polymerization of isobutylene: highly branched polyisobutylene and an isobutylene-ethyl acrylate copolymer.
PMID 19215097·J Am Chem Soc·2009
8-other
Integrating microarray analysis and the soybean genome to understand the soybeans iron deficiency response.
PMID 19678937·BMC Genomics·2009
8-other
Polymerizable vancomycin derivatives for bactericidal biomaterial surface modification: structure-function evaluation.
PMID 19606854·Biomacromolecules·2009
8-other
Gene expression-signature of belinostat in cell lines is specific for histone deacetylase inhibitor treatment, with a corresponding signature in xenografts.
PMID 19606018·Anticancer Drugs·2009
7-preclinical
Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming.
PMID 19330000·Nat Biotechnol·2009
8-other
Identification of candidate signaling genes including regulators of chromosome condensation 1 protein family differentially expressed in the soybean-Phytophthora sojae interaction.
PMID 18825360·Theor Appl Genet·2009
8-other
Increased antitumor activity of bevacizumab in combination with hypoxia inducible factor-1 inhibition.
PMID 19584228·Mol Cancer Ther·2009
7-preclinical
Crystal structure of checkpoint kinase 2 in complex with NSC 109555, a potent and selective inhibitor.
PMID 19177354·Protein Sci·2009
8-other
Gene expression profiling of alveolar soft-part sarcoma (ASPS).
PMID 19146682·BMC Cancer·2009
4-observational
An integrated approach to identifying cis-regulatory modules in the human genome.
PMID 19434238·PLoS One·2009
8-other
Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosa.
PMID 19093800·J Nat Prod·2009
8-other
Cytotoxic and HIF-1alpha inhibitory compounds from Crossosoma bigelovii.
PMID 19405508·J Nat Prod·2009
8-other
Establishment of a soybean (Glycine max Merr. L) transposon-based mutagenesis repository.
PMID 18855007·Planta·2009
8-other
Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy.
PMID 19636271·J Pediatr Hematol Oncol·2009
7-preclinical
Identification of polymerase and processivity inhibitors of vaccinia DNA synthesis using a stepwise screening approach.
PMID 18621425·Antiviral Res·2008
7-preclinical
Biomechanical comparison of six suture configurations using a large diameter polyester prosthesis in the muscular process of the equine arytenoid cartilage.
PMID 19134109·Vet Surg·2008
7-preclinical
Induction of apoptosis in human cancer cells by candidaspongiolide, a novel sponge polyketide.
PMID 18728285·J Natl Cancer Inst·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 732 THIMBLE SHOALS BLVD STE 803
NEWPORT NEWS, VA 23606 - Phone
- (757) 933-8888
Quick Facts
- NPI
- 1275978017
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile